首页> 外国专利> Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, its production process

Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, its production process

机译:用于制备抗微生物制剂输注溶液的药物组合物及其生产方法

摘要

The present invention relates to pharmacology, medicine, veterinary science and pharmaceutical industry, namely to pharmaceutical compositions for the preparation of infusion solutions of antimicrobial preparations potentiating the therapeutic efficacy of antimicrobial medicaments, during the process of preparing solutions thereof immediately before carrying out intravenous infusions and the process of producing original composite pharmaceutical ingredients. The claimed pharmaceutical compositions for the preparation of injection solutions of all the tested antimicrobial preparations comprising the finely dispersed powder of nanostructured colloidal silica, reliably increase their therapeutic efficacy when treating generalised sepsis in test animals, provoked by Staphylococcus aureus, Escherichia coli, Pseudo-monas aeruginosa and Candida albicans. The claimed pharmaceutical compositions for the preparation of antibacterial and antifungal preparations solutions for intravenous infusions (NaCl:Colloidal silica and Dextrose:Colloidal silica) have a significant clinically sginificant potentiating action on their therapeutic potential when treating inflammatory infectious disease, in comparison with traditional solvents (prototypes of the invention).
机译:本发明涉及药理学,医学,兽医学和制药工业,即涉及用于在制备药物溶液的过程中立即制备抗微生物药物的治疗效果的药物组合物,所述抗微生物药物的溶液在即将进行静脉内输注之前制备其溶液的过程中。生产原始复合药物成分的过程。所要求保护的用于制备所有测试的抗微生物制剂的注射溶液的药物组合物,其包含由纳米结构的胶体二氧化硅细分散的粉末,当治疗由金黄色葡萄球菌,大肠杆菌,假单胞菌引起的全身性败血症时,能可靠地提高其治疗功效。铜绿假丝酵母和白色念珠菌。要求保护的用于制备用于静脉输注的抗菌和抗真菌制剂溶液的药物组合物(NaCl:胶体二氧化硅和右旋糖:胶体二氧化硅)与传统溶剂相比,在治疗炎性感染性疾病时对它们的治疗潜力具有显着的临床增效作用(本发明的原型)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号